Neuroblastoma in the very young child: biological considerations.
Explore this paper's citation graph
Summary
The data that has led to this conclusion and the biological characteristics that are associated with the different forms of the neuroblastoma will be reviewed, and a brief outline of new studies which may identify some of the factors associatedwith the neuroblasts ability to metastasise will be discussed.
- Type
- article
- Published
- 1992-08-01
- Cited by
- 7
- References
- 34
- Access
- Open access
- OpenAlex
- https://openalex.org/W160658965
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:20871006
Keywords
Neuroblastoma, Disease, Medicine, Neuroblast, Stage (stratigraphy)
References
- Cancer in neonates: the experience at the Children's Hospital of Philadelphia.
- Histopathologic prognostic factors in neuroblastic tumors: definition of subtypes of ganglioneuroblastoma and an age-linked classification of neuroblastomas.
- US cancer incidence and mortality in the first year of life.
- Prognostic factors in Neuroblastoma. Clinical, histopathologic, and immunohistochemical features and DNA ploidy in relation to prognosis
- Expression of alternative isoforms of the neural cell adhesion molecule (NCAM) on normal brain and a variety of brain tumours
- Molecular biology and genetics of human neuroblastoma.
- Amplified DNA with limited homology to myc cellular oncogene is shared by human neuroblastoma cell lines and a neuroblastoma tumour
- A proposed staging for children with neuroblastoma. Children's cancer study group A
- Congenital neuroblastoma, neuroblastoma in situ, and the normal fetal development of the adrenal.
- The 200/220 kDa Antigen Recognized by Monoclonal Antibody (MAb) UJ127.11 on Neural Tissues and Tumors Is the Human L1 Adhesion Molecule
- Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage.
- High-resolution in situ hybridization technique using biotinylated NMYC oncogene probe reveals periodic structure of HSRs in human neuroblastoma.
- Neural cell adhesion molecule (NCAM) is the antigen recognized by monoclonal antibodies of similar specificity in small‐cell lung carcinoma and neuroblastoma
- N-myc gene product expression in neuroblastoma.
- Autonomous growth of a human neuroblastoma cell line is mediated by insulin-like growth factor II.
- Use of panels of monoclonal antibodies in the differential diagnosis of neuroblastoma and lymphoblastic disorders.
- Amplified N-myc in human neuroblastoma cells is often arranged as clustered tandem repeats of differently recombined DNA
- Cytogenetic features of human neuroblastomas and cell lines.
- Cell surface membrane antigen present on neuroblastoma cells but not fetal neuroblasts recognized by a monoclonal antibody (KP-NAC8).
- International criteria for diagnosis, staging and response to treatment in patients with neuroblastoma.
Cited by
- NEUROBLASTOMA EN NINOS MENORES DE 1 ANO
- Neuroblastoma in infants aged less than 6 months: is more aggressive treatment necessary? A report from the Pediatric Oncology Study Group of the Kyushu area.
- Revisions of the international criteria for neuroblastoma diagnosis, staging and response to treatment.
- Spontaneous regression of cancer.
- Is genomic imprinting involved in the pathogenesis of pseudotriploid neuroblastoma?
- Neonatal Tumours
- Epidemiology of Neonatal Tumours
Related papers
- Activated β-catenin Forces N2A Cell-derived Neurons Back to Tumor-like Neuroblasts and Positively Correlates with a Risk for Human Neuroblastoma
- Neuroblastoma cells with overexpressed MYCN retain their capacity to undergo neuronal differentiation
- [Protective Effects of Myelopeptides in Neuroblastoma C-1300 Cell Culture].
- Single-cell transcriptomic analyses provide insights into the developmental origins of neuroblastoma
- MYCN promotes the expansion of Phox2B-positive neuronal progenitors to drive neuroblastoma development.
- A Primer for Assessing the Pathology in Mouse Models of Neuroblastoma
- Neuroblastoma incidence in Europe: Why is there more high stage disease and less low stage disease in British children?
- Infantile neuroblastoma: 10 year TMH experience.
- Disseminated neuroblastoma (stage IV and IV‐S) in the first year of life. Outcome related to age and stage